“DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS”. 2025. International Journal of Artificial Intelligence 5 (09): 221-23. https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299.